The multi-institutional symposium will cover cardiovascular toxicities, risk stratification, and include case presentations. (for providers & researchers)
The burden of care after breast cancer treatment is on oncologists, other specialists & primary care providers. Here's a new Duke-edited guide for treating survivors.
The Duke Cardio-Oncology program hosts a webinar on identifying and managing cardio-toxicities in patients undergoing cancer treatment. CE is available.
For breast cancer patient Erin Hatcher, participating in a research study to learn about the potential for heart-related side effects of chemotherapy is a “win-win” situation to protect her health in the future.
Susan Dent, MD, co-director of the Duke Cardio-Oncology Program, is a leading international expert in the field. She is also associate director of Clinical Research in DCI's Breast Program.
Susan Dent, MD, FRCPC, is the new co-leader of Duke’s efforts in cardio-oncology and new associate director of breast cancer clinical research. She joined DCI in September 2018.
Cardiologist Chiara Melloni became interested in the emerging field of cardio-oncology after her father developed heart problems while being treated for lung cancer.
Medical oncologist Susan F. Dent, MD, FRCPC, was recently named associate director for clinical research for Breast Oncology and co-director of Duke C...
Duke Cancer Institute breast oncologist Gretchen Kimmick, MD, MS, is chief editor of a new textbook — “Cardio-Oncology: The Clinical Overlap of Cancer...